Exploring Three High Growth Tech Stocks in the United States

In This Article:

Over the last 7 days, the United States market has remained flat, yet it has risen by an impressive 39% over the past 12 months, with earnings forecasted to grow by 15% annually. In this context of robust growth and stability, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation potential and adaptability within this dynamic sector.

Top 10 High Growth Tech Companies In The United States

Name

Revenue Growth

Earnings Growth

Growth Rating

Super Micro Computer

21.08%

28.73%

★★★★★★

Sarepta Therapeutics

23.80%

44.01%

★★★★★★

TG Therapeutics

30.63%

46.00%

★★★★★★

Ardelyx

27.19%

66.44%

★★★★★★

Invivyd

42.91%

70.39%

★★★★★★

Amicus Therapeutics

20.26%

62.89%

★★★★★★

MediaAlpha

26.82%

83.70%

★★★★★★

Travere Therapeutics

29.32%

70.79%

★★★★★★

Seagen

22.57%

71.80%

★★★★★★

ImmunoGen

26.00%

45.85%

★★★★★★

Click here to see the full list of 247 stocks from our US High Growth Tech and AI Stocks screener.

Here we highlight a subset of our preferred stocks from the screener.

Natera

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Natera, Inc. is a diagnostics company that develops and commercializes molecular testing services globally, with a market cap of approximately $14.93 billion.

Operations: The company generates revenue primarily through the development and commercialization of molecular testing services, totaling $1.36 billion.

Natera, a player in the biotech sector, is navigating through its growth phase with significant R&D investments and promising revenue projections. In 2024, the company's R&D expenses were substantial, aligning with its strategic focus on enhancing molecular diagnostic technologies. This investment supports a forecasted annual revenue growth of 13.3%, outpacing the US market average of 8.9%. Moreover, Natera's recent presentation at ESMO highlighted breakthroughs from its GALAXY trial for colorectal cancer, showcasing Signatera's potential to significantly impact patient survival outcomes. These innovations not only underscore Natera’s commitment to advancing healthcare but also position it favorably in a competitive landscape where technological efficacy and advancement drive growth.

NasdaqGS:NTRA Earnings and Revenue Growth as at Oct 2024
NasdaqGS:NTRA Earnings and Revenue Growth as at Oct 2024

PTC

Simply Wall St Growth Rating: ★★★★★☆

Overview: PTC Inc. is a software company that operates in the Americas, Europe, and the Asia Pacific with a market capitalization of approximately $22.26 billion.

Operations: PTC generates revenue primarily from its CAD/CAM software segment, which accounts for approximately $2.22 billion.